生物活性 | |||
---|---|---|---|
描述 | α-Glucosidase-IN-22, characterized as a benzimidazole compound, displays potent inhibition against α-glucosidase with an IC50 of 0.64 μM. It functions as a potent anti-diabetic agent and holds promise for type 2 diabetes mellitus (T2DM) research [1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.50mL 0.70mL 0.35mL |
17.52mL 3.50mL 1.75mL |
35.05mL 7.01mL 3.50mL |
参考文献 |
---|